Pages that link to "Q52609661"
Jump to navigation
Jump to search
The following pages link to Advances in HIV-1 Vaccine Development. (Q52609661):
Displaying 11 items.
- Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B (Q89633807) (← links)
- Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies (Q90024145) (← links)
- Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy (Q90176802) (← links)
- Striking a balance in an antibody network: A roadmap for HIV-1 vaccines (Q90555353) (← links)
- An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design (Q91813907) (← links)
- The situation of vaccines for the prevention of infections in adults: An opinion paper on the situation in Spain (Q92178995) (← links)
- Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination (Q92258141) (← links)
- Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae (Q92502992) (← links)
- Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses (Q92538912) (← links)
- Network-Based Analysis of OMICs Data to Understand the HIV-Host Interaction (Q97067564) (← links)
- RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines (Q98611597) (← links)